Clinical Trial

Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression

Recruiting
View on ClinicalTrials.gov →
Summary
The study evaluates the effect of HBOT on depression in patients suffering from persistent symptoms of post stroke depression (PSD) in an double blind sham control study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-18.
Trial Details
NCT Number NCT07423273
Lead Sponsor Assaf-Harofeh Medical Center
Conditions Post Stroke Depression
Enrollment 142 participants
Start Date 2023-11-08
Primary Completion 2030-12-01 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-17